ABBOTT RAPID DX INTERNATIONAL LIMITED

Abbott Rapid Dx International Limited is a leading provider of rapid, point-of-care diagnostic solutions that help clinicians make faster, more informed decisions at the bedside. By delivering accurate test results within minutes, the company supports the diagnosis, monitoring and management of a wide range of conditions-from myocardial infarction and metabolic disturbances to infectious diseases such as COVID-19 and influenza.

The portfolio includes the i-STAT system with the new hs-TnI cartridge for cardiac markers, the compact Afinion™ 2 multi-assay analyser, the ID NOW platform that can test for COVID-19 alone or together with influenza A & B from a single swab, and the Panbio™ COVID-19 antigen self-test. Additional offerings such as the Cholestech LDX™ finger-stick analyser provide immediate lipid and glucose results. Abbott also backs its products with comprehensive technical support, product demos and documentation, ensuring healthcare professionals have the resources they need to deliver timely, patient-centred care.